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Mycoplasma hyopneumoniae is an economically-devastating and geographically-widespread pathogen 
that colonises ciliated epithelium, and destroys mucociliary function. M. hyopneumoniae devotes 
~5% of its reduced genome to encode members of the P97 and P102 adhesin families that are critical 
for colonising epithelial cilia, but mechanisms to impair mucociliary clearance and manipulate host 
immune response to induce a chronic infectious state have remained elusive. Here we identified two 
surface exposed M. hyopneumoniae proteases, a putative Xaa-Pro aminopeptidase (MHJ_0659; PepP) 
and a putative oligoendopeptidase F (MHJ_0522; PepF), using immunofluorescence microscopy and 
two orthogonal proteomic methodologies. MHJ_0659 and MHJ_0522 were purified as polyhistidine 
fusion proteins and shown, using a novel MALDI-TOF MS assay, to degrade four pro-inflammatory 
peptides that regulate lung homeostasis; bradykinin (BK), substance P (SP), neurokinin A (NKA) and 
neuropeptide Y (NPY). These findings provide insight into the mechanisms used by M. hyopneumoniae 
to influence ciliary beat frequency, impair mucociliary clearance, and initiate a chronic infectious disease 
state in swine, features that are a hallmark of disease caused by this pathogen.
Mycoplasma hyopneumoniae is the etiological agent of porcine enzootic pneumonia, a highly infectious and glob-
ally distributed swine respiratory disease. Symptoms of enzootic pneumonia include growth rate retardation, 
reduced feed conversion, and higher susceptibility to secondary bacterial1 and viral infections, including porcine 
reproductive and respiratory syndrome virus (PRRSV), swine influenza virus (SIV) and porcine circovirus type 
2 (PCV2)2,3. Many broad-spectrum antibiotics are used to treat M. hyopneumoniae infections specifically, but a 
greater number of antibiotics are used to prevent polymicrobial respiratory infections4. Thus M. hyopneumoniae 
is a significant contributor to antibiotic use in swine production. In 1991, M. hyopneumoniae caused an estimated 
$1 billion economic loss in the USA alone5. This estimate did not account for the impact incurred by animal waste 
containing large quantities of multiple antibiotic resistant bacterial populations6. Animal waste including pig 
effluent is used as organic fertiliser on agricultural lands, particularly in China7, the world’s largest producer of 
pork. While no current economic burden estimates have been published, a 2006 survey of nineteen large US pig 
production companies ranked the estimated losses associated with M. hyopneumoniae alone and M. hyopneumo-
niae in conjunction with PRRSV among the top challenges with the highest estimated average loss for all pigs8.
Bacterin vaccines are used to control M. hyopneumoniae in conjunction with antibiotics; however, their effi-
cacy is limited due to a minimal reduction in pathogen transmission and high production cost9. There is a need 
to enhance our understanding of M. hyopneumoniae pathogenesis to develop more efficacious vaccines and ther-
apeutics that seek to eradicate this pathogen by preventing colonisation of the respiratory tract and reducing 
reliance on antibiotics.
The mucociliary escalator is a major innate barrier to all infectious respiratory microorganisms. It lines the 
respiratory tract and is composed of mucus-secreting goblet cells and ciliated epithelium. Mucus traps inhaled 
particles that are then propelled to the pharynx by the synchronised beating of cilia to be either swallowed or 
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expectorated10. M. hyopneumoniae avoids mucociliary clearance by disrupting the mucociliary escalator by 
initiating ciliostasis, loss of cilia function, and epithelial cell death. However, these sequelae are poorly under-
stood11. Cilioinhibitory factors deployed by other respiratory pathogens to disrupt the mucociliary system, such 
as the toxin pneumolysin of Streptococcus pneumoniae12 or the low molecular weight glycopeptides produced 
by Haemophilus influenzae13, have not been described for M. hyopneumoniae. The human respiratory pathogen, 
Mycoplasma pneumoniae, causes allergic-type inflammation by secreting the community-acquired respiratory 
distress syndrome (CARDS) toxin14, though homologues of this toxin have not been found in M. hyopneumo-
niae. A recent study demonstrated that M. hyopneumoniae signal peptidase I is cytotoxic to mammalian cells15, 
however this protease is not surface expressed or secreted16,17. While mycoplasmas can cause some direct tissue 
damage through the production of the metabolic by-product hydrogen peroxide18, this is not necessarily linked 
with pathology. For example, mutants of Mycoplasma gallisepticum, a major respiratory pathogen of poultry that 
are incapable of producing hydrogen peroxide, are virulent in a native host pathogenesis model19.
Many bacterial species are known to manipulate host defences by actively attracting immune effector cells to 
the site of infection, because host-derived proteases, released by neutrophils and macrophages, are often more 
efficient at degrading extracellular matrix (ECM) components than bacterial-derived proteases20. Host-induced 
ECM proteolysis represents a mechanism to source nutrients, a process that is vital for genome-reduced organ-
isms, such as M. hyopneumoniae, unable to synthesise amino acids, nucleotides, fatty acids and other macromo-
lecular building blocks21,22.
Mycoplasmas adhere to respiratory epithelium and elicit many defence mechanisms. These include the induc-
tion of pro-inflammatory cytokines such as tumour necrosis factor alpha (TNFα), interleukin (IL) 1β, IL6, and 
IL8, stimulation of lymphocytes, and increase the cytotoxicity of macrophages and natural killer (NK) cells23. 
Non-self-recognition also up-regulates several other respiratory defence mechanisms. Antimicrobial peptides 
(AMPs), such as lactoferrin, lysozyme, and cathelicidins are secreted from respiratory epithelium and not only 
directly destroy pathogens but also act as effector molecules regulating both innate and adaptive immune systems24. 
Inflammation is intensified by microbe-induced activation of enzymatic cascades, including the kallikrein/kinin 
system which releases bradykinin (BK), a potent bronchoconstrictor and pro-inflammatory peptide25. Neurogenic 
inflammation also plays a significant role in the innate immune response to infections, with non-myelinated 
C-fibres innervating the majority of the lung26. These fibres secrete neuropeptides such as neuropeptide Y (NPY), 
substance P (SP), and neurokinin A (NKA), the two latter of which are similar to AMPS in both structure and 
function27, and are known to stimulate mucus secretion and increased ciliary beat frequency (CBF)28,29.
Despite fostering a formidable immune response, M. hyopneumoniae is associated with chronic illness. 
Maintaining a balance of contrasting immunologic responses is therefore likely to impact virulence and disease 
progression. Host effector molecules and their receptors are susceptible to proteolytic modifications by bacterial 
proteases that render them either active or inactive20. Despite evolving via a process of genome decay, M. hyo-
pneumoniae has retained the genetic capacity to express several putative proteases, five of which were observed to 
be overrepresented in pathogenic M. hyopneumoniae strains17, yet how these may affect their host has not been 
fully explored. For example, proteolytic activity against kallikrein-kinin system substrates, such as BK, has been 
demonstrated in M. hyopneumoniae and other mycoplasmas, however the proteases behind this activity have only 
been speculated on30,31. Here we show using several complementary, orthogonal methods that two proteases - 
MHJ_0659, a putative Xaa-Pro aminopeptidase (PepP), and MHJ_0522, a putative oligoendopeptidase F (PepF) 
- are exposed on the surface of M. hyopneumoniae. MHJ_0659 and MHJ_0522 were purified as recombinant pol-
yhistidine fusion proteins using nickel-affinity chromatography and their enzymatic properties against substrates 
involved in mucociliary clearance, namely BK, SP, NKA, and NPY were assessed with different metal ion cofactors 
at different pHs using a MALDI-TOF/TOF MS/MS protocol.
Results
Identification and localisation of MHJ_0659 and MHJ_0522 in M. hyopneumoniae. Despite a 
PSORT prediction for a cytoplasmic localisation for MHJ_0659 and MHJ_0522, mild enzymatic cell shaving 
experiments using trypsin identified tryptic peptides matching MHJ_0659 (Fig. 1d; one peptide) and MHJ_0522 
(Fig. 2d; three peptides). In a second, independent set of experiments in which freshly cultured M. hyopneumo-
niae cells were labelled with biotin, and surface-exposed biotinylated proteins were recovered using avidin chro-
matography, LC-MS/MS identified peptides that also mapped to MHJ_0659 (Fig. 1d; one peptide) and MHJ_0522 
(Fig. 2d; two peptides). Specificity of anti-sera generated against MHJ_0659 and MHJ_0522 was checked via 
Western Blotting (Figs 1b and 2b). To confirm the surface localisation of both proteases, we labelled the surface 
of freshly cultured M. hyopneumoniae with rabbit anti-MHJ_0659 and anti-MHJ_0522 antibodies and detected 
them with anti-rabbit antibodies conjugated with CFTM 568 (Figs 1c and 2c).
Biochemical characterisation of functionally active rMHJ_0659. rMHJ_0659 was purified from 
Escherichia coli as a polyhistidine fusion protein and resolved as a single band with a mass of approximately 
40 kDa by SDS-PAGE (Fig. 1a). This protein was recovered from the gel, digested with trypsin and confirmed to 
be MHJ_0659 by LC-MS/MS (46% sequence coverage) (Fig. 1d). rMHJ_0659 was able to remove the N-terminal 
penultimate proline from BK (Fig. 3), SP (Fig. 4) and NPY (Fig. 5) in a manner that is typical of a PepP protease.
rMHJ_0659 cleaves bradykinin (BK). The BK1-7 fragment [RPPGFSP] of bradykinin has a molecular 
mass of 757 Da. In the absence of rMHJ_0659, a single prominent peak at 757.40 Da representing the mass of 
BK1-7 was observed by MALDI-TOF/MS (Fig. 3a). Once BK1-7 was incubated with rMHJ_0659 two additional 
peaks were identified with masses of 601.30 Da and 504.27 Da (Fig. 3b). The 601.30 Da peak represents the mass 
of BK2-7 [PPGFSP] which arises by the removal of arginine from the N-terminus (R = 156.1 Da). The 504.27 Da 
peak equates to BK3-7 [PGFSP] and is the product of removal of the proline residue in position P2’ (P = 97.1 Da). 
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The effect of divalent cofactors Ca2+, Co2+, Mg2+, Mn2+ and Zn2+ at pH of 5, 6.3, 7.3 and 8.8 on rMHJ_0659 activ-
ity was also assessed. rMHJ_0659 had the highest activity in the presence of Ca2+ at all pH levels tested. The metal 
chelating agent EDTA in the presence of Ca2+ suppressed activity at all pH levels tested (Fig. 3c).
rMHJ_0659 cleaves substance P (SP). SP is an undecapeptide [RPKPQQFFGLM-NH2] with a mass of 
1347.63 Da. When rMHJ_0659 was incubated with SP for an hour at 37 °C, the N-terminal arginine residue was 
removed generating the fragment SP2-11 [PKPQQFFGLM-NH2] with a mass of 1191.66 Da (Fig. 4b). This cleavage 
only occurred at pH 8.8, with cofactor Ca2+ and Mg2+ producing the most intense peaks. EDTA in the presence 
of Ca2+ suppressed activity compared to Ca2+ alone (Fig. 4c).
rMHJ_0659 cleaves neuropeptide Y (NPY). NPY is a 36 amino acid peptide [1YPSK…RQRY36] with 
a molecular mass of 4254.70 Da. A single peak at 4091.83 Da representing NPY minus the N-terminal tyrosine 
residue (Y = 163 Da) was detected when NPY was incubated with rMHJ_0659 in the presence of various divalent 
metal cofactors across a pH range of 5 to 8.8 for 1 hour at 37 °C (Fig. 5a). The peak at 4091.83 Da was not evident 
when rMHJ_0659 was incubated with NPY at pH 5.0. Minor cleavage of NPY was evident at pH 6.3 in the pres-
ence of Mg2+, Ca2+ and Mn2+. At pH 7.5, the metal ion cofactor Ca2+ provided the most favourable conditions 
for cleaving NPY. rMHJ_0659 cleaved NPY with maximum efficiency at pH 8.8 in the presence of different metal 
ion cofactors. EDTA suppressed Mg2+ mediated activity at pH 6.3, and Ca2+ activity at pH 7.5 and 8.8 (Fig. 5b).
Biochemical Characterisation of rMHJ_0522
rMHJ_0522 (predicted MW of 71 kDa) resolves during SDS-PAGE as a single band with a mass of approximately 
70 kDa (Fig. 2a). The protein band was digested with trypsin and confirmed to be rMHJ_0522 by LC-MS/MS (51% 
sequence coverage) (Fig. 2d). rMHJ_0522 cleaved full-length BK (Fig. 6), SP (Fig. 7) and NKA (Fig. 8). Unlike 
rMHJ_0659, rMHJ_0522 was not active at pH 5. rMHJ_0522 did not cleave BK1-7 nor did it cleave NPY, which 
is 36 amino acids in length. These data are consistent with rMHJ_0522 functioning as an oligoendopeptidase.
rMHJ_0522 cleaves bradykinin (BK). Full-length BK [RPPGFSPFR] has a molecular mass of 1060.21 Da. 
In the absence of rMHJ_0522, a single prominent peak at 1060.21 Da was observed in MALDI-TOF MS spectra 
(Fig. 6a). When BK was incubated with rMHJ_0522, three additional peaks were observed, 652.74 Da, 572.66 Da, 
and 505.57 Da (Fig. 6b). The peaks at 572.66 Da and 505.57 Da are products of a single cleavage event; 572.66 Da 
represents the mass of BK1-5 [RPPGF], and 505.57 Da represents the mass of BK6-9 [SPFR], indicating the cleavage 
event occurs at RPPGF↓SPFR. The peak at 652.74 Da equates to the mass of BK5-9 [FSPFR] thus represents another 
cleavage event at RPPG↓FSPFR. The effect of divalent cofactors Ca2+, Co2+, Mg2+, Mn2+ and Zn2+ and pH on the 
activity of rMHJ_0522 was determined. At pH 6.3, Mn2+ and Mg2+ produced the most intense peak for BK5-9, and 
Figure 1. MHJ_0659 is detected on the surface of M. hyopneumoniae. (a) rMHJ_0659 resolves as a single band 
at approximately 39 kDa under denaturing conditions during SDS-PAGE. (b) Western blot demonstrating 
anti-MHJ_0659 sera specificity. (c) Two representative examples of M. hyopneumoniae cells stained with the 
nucleic acid stain DAPI (blue) and probed with both rabbit anti-MHJ_0659 serum and anti-rabbit antibodies 
conjugated to CFTM 568 (red). Bars represents 0.5 µm. (d) MHJ_0659 amino acid sequence. Tryptic peptides 
(red) identified by LC-MS/MS after the 39 kDa rMHJ_0659 protein was digested in-gel with trypsin. The 
underlined peptide was identified by LC-MS/MS after biotinylated surface proteins were recovered by avidin 
chromatography and digested with trypsin. Mascot identity score – 77.5; Mascot ion score – 89.4; Delta score 
39.0; Peptide prophet – 97%. The dashed underlined peptide in bold was identified by LC-MS/MS after mild 
trypsin digestion of cell surface proteins. Mascot identity score – 68; Mascot ion score – 96.1; Delta score – 67.5; 
Peptide prophet – 99%.
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both Ca2+ and Zn2+ produced the most intense peaks for BK1-5. A similar profile was seen at pH 7.3; only Mn2+ 
joined Ca2+ and Zn2+ in producing the most intense peak for BK1-5. In basic conditions (pH ≥ 7.5), only Mg2+ 
produced intense peaks for BK5-9, and Ca2+ and Co2+ produced the most intense peaks for BK1-5 (Fig. 6c). EDTA 
supressed Ca2+ mediated activity at pH 6.3 and pH 8.8, and Mn2+ mediated activity at pH 7.5 (Fig. 6c).
rMHJ_0522 cleaves substance P (SP). Full-length SP [RPKPQQFFGLM-NH2] has a molecular mass of 
1347.67 Da and control experiments demonstrated a single ion peak at this mass (Fig. 7a). When SP was incu-
bated with rMHJ_0522 additional peaks were observed at 1047.57 Da, 1104.61 Da and 1217.02 Da corresponding 
to the mass of SP fragments SP1-8 [RPKPQQFF], SP1-9 [RPKPQQFFG], and SP1-10 [RPKPQQFFGL], respec-
tively (Fig. 7b). The most prevalent cleavage fragment generated at all pHs (6.3, 7.3 & 8.8) and cofactors (Ca2+, 
Co2+, Mg2+, Mn2+, and Zn2+) tested was SP1-8 (Fig. 7c), however at pH 7.3 in the presence of Zn2+ and Ca2+, 
SP1-9 and SP1-10 were also produced, albeit at lower intensities (Fig. 7c). This data indicates that rMHJ_0522 
can produce cleavage events at RPKPQQFF↓G↓L↓M (first arrow indicates most prominent cleavage). EDTA sup-
pressed Ca2+ mediated activity at pH 6.3 and pH 8.8, and Zn2+ mediated activity at pH 7.5 (Fig. 7c).
rMHJ_0522 cleaves neurokinin A (NKA). Full-length NKA [HKTDSFVGLM-NH2] has a molecular 
mass of 1134.31 Da and a single ion at that mass was detected in control experiments (Fig. 8a). When NKA was 
incubated with rMHJ_0522, additional peaks were observed at 733.77 Da, 832.90 Da and 889.95 Da correspond-
ing to the mass of NKA fragments NKA1-6 [HKTDSF], NKA1-7 [HKTDSFV], and NKA1-8 [HKTDSFVG], 
respectively (Fig. 8b). At pH 6.3 and only in the presence of Ca2+, Co2+ and Mg2+ did rMHJ_0522 produce 
non-negligible cleavage fragments of NKA. NKA1-6 and NKA1-7 were the most common cleavage fragment in 
the presence of Mg2+ and NKA1-8 the most prominent in the presence of Co2+. At pH 7.3, Zn2+ was the most 
effective cofactor, producing NKA1-8 as the most predominant fragment. Unlike BK and SP, no activity against 
NKA was observed at pH 8.8. EDTA suppressed Mg2+ mediated activity at pH 6.3 and Zn2+ mediated activity at 
pH 7.5 (Fig. 8c).
Figure 2. MHJ_0522 is detected on the surface of M. hyopneumoniae cells. (a) An SDS-PAGE gel of purified 
rMHJ_0522. The protein resolves as a monomer of approximately 70 kDa. (b) Western blot demonstrating 
anti-MHJ_0522 sera specificity. (c) Image illustrating the surface localisation of MHJ_0522 after whole M. 
hyopneumoniae cells were probed with rabbit anti-MHJ_0522 serum and anti-rabbit antibodies conjugated 
to CFTM 568 (red). M. hyopneumoniae cells were also stained with the nucleic acid stain DAPI (blue). Bars 
represents 0.5 µm. (d) Tryptic peptides (red) that map to rMHJ_0522 provide 51% sequence coverage and 
confirm the identity of the purified recombinant protein. Tryptic peptides that are dash underlined and bold 
were those identified after mild trypsin digestion of the cell surface of M. hyopneumoniae. Tryptic peptides that 
are underlined were identified after biotinylated surface proteins were recovered by avidin chromatography and 
digested with trypsin.
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Figure 3. Cleavage of BK1-7 by rMHJ_0659 is influenced by pH and metal ion cofactors. (a) MALDI-TOF/MS 
spectra demonstrating a single peak at 757.4 Da that represents the mass of bradykinin fragment 1-7 (BK1-7).  
(b) MALDI-TOF/MS spectra of bradykinin peptide fragments and amino acids released after incubating BK1-7 
with rMHJ_0659 for 1 hr in the presence of Co2+ at pH 7.5. Additional peaks observed at 601.3 Da (BK2-7) 
and 504.3 Da (BK3-7) represent the loss of an R residue, and loss of R and P residues respectively from the 
N-terminus of BK1-7. (c) At pH 5, the most prominent peak was the parent BK1-7. Smaller amounts of cleavage 
products BK2-7 and BK3-7 were detected at pH 5. At all pH levels tested, Ca2+ followed by Mg2+ produced the 
most intense peaks at a mass of 504.3 Da representing BK3-7. EDTA suppressed Ca2+ mediated activity at all pH 
levels tested. Control refers to BK1-7 in the absence of rMHJ_0659.
Figure 4. Cleavage of SP by rMHJ_0659 is influenced by pH and metal ion cofactors. (a) SP in the absence 
of rMHJ_0659 is represented as a single prominent peak at 1347.8 Da using MALDI-MS. (b) After SP was 
incubated with rMHJ_0659, the prominent peak was at 1191.7 Da. This ion represents the mass of SP minus the 
N-terminal arginine residue (SP fragment SP2-11). (c) The generation of SP2-11 occurred at pH 8.8 and was 
greatest in the presence of Ca2+ and Mg2+ and EDTA suppressed activity of Ca2+. Control refers to SP1-11 in the 
absence of rMHJ_0659.
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rMHJ_0659 and rMHJ_0522 share substrates and have the potential to cleave many biologically 
active proteins. rMHJ_0659 was shown to cleave at N-terminal penultimate prolines when the N-terminal 
amino acid was arginine (BK and SP), proline (BK second cleavage) and tyrosine (NPY). rMHJ_0522 cleaved BK 
at glycine and phenylalanine, SP at phenylalanine, glycine and leucine, and NKA at phenylalanine, valine, and gly-
cine (Table 1). BK and SP were common substrates for both proteases. Interestingly, penultimate prolines are pres-
ent at the N-terminal of many porcine innate immune system polypeptides, and the FXGLM-NH2 motif is common 
to all tachykinins, the largest family of neuropeptides (Table 2). We propose that these innate effector peptides and 
neuropeptides are potential substrates for PepP and PepF proteases on the surface of M. hyopneumoniae.
Discussion
M. hyopneumoniae enters the porcine respiratory tract on mucosal droplets expelled during bouts of coughing 
from infected animals. In naïve animals, these droplets are inhaled and are likely to be captured by the mucocili-
ary escalator that forms an effective barrier to invading pathogens. The ability of this porcine-specific pathogen to 
survive as a species is contingent on being able to colonise cilia that beat with a frequency of ~13 hertz in normal 
uninfected tissue and overcome the mucociliary escalator32. A toxin that can disrupt mucociliary clearance by 
Figure 5. Cleavage of NPY by rMHJ_0659 is influenced by pH and metal ion cofactors. (a) Superimposed 
image of two MALDI-TOFMS spectras showing NPY in the absence of rMHJ_0659 represented by a peak at 
4254.7 Da (blue arrow) and after incubation with rMHJ_0659 in the presence of Co2+ at pH 8.8 (red arrow). The 
peak at 4091.8 Da represents the mass of NPY after removal of tyrosine. (b) rMHJ_0659 cleaved NPY with the 
greatest efficiency at pH 8.8 in the presence of the metal ion cofactors Ca2+, Co2+, Mg2+, Mn2+, and Zn2+. EDTA 
suppressed Mg2+ (pH 6.3) and Ca2+ (pH 7.5 and pH 8.8) – mediated activity. Control refers to NPY1-36 in the 
absence of rMHJ_0659.
Figure 6. Cleavage of BK by rMHJ_0522 is influenced by pH and divalent metal cofactors. (a) Control spectra 
of BK in the absence of rMHJ_0522. (b) and (c) rMHJ_0522 produces fragments BK1-5, BK5-9, and BK6-9 at 
pH 6, 7.3 and 8.8 and in the presence of all cofactors tested. However, the intensity of each peak varies implying 
that at different pH levels and in the presence of various cofactors certain cleavages are more prevalent. EDTA 
suppressed Ca2+ mediated activity at pH 6.3 and pH 8.8, and suppressed Mn2+ mediated activity at pH 7.5. 
Control refers to BK1-9 in the absence of rMHJ_0522.
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slowing or blocking ciliary beat frequency has not been identified in M. hyopneumoniae, yet it is highly adept 
at colonising ciliary epithelium. M. hyopneumoniae devotes more than 5% of its reduced genome23 to encoding 
multifunctional and highly-processed cilium adhesion proteins16,33–36 that can also bind glycosaminoglycans35,37, 
extracellular actin38, plasminogen39,40 and fibronectin39,41, all important components of the extracellular matrix of 
host cells. The ability of M. hyopneumoniae to bind to porcine cilia is abrogated by the exogenous addition of the 
glycosaminoglycan heparin42, actin38 and by treating cilia with heparinase43. Unsurprisingly, M. hyopneumoniae 
adhesins have been explored previously as vaccine targets, though they have proved less effective than the bacte-
rin vaccines currently available44,45. This may be due to the growing discovery of M. hyopneumoniae surface pro-
teins with adhesion moonlighting capacities46,47. Here we describe a novel enzymatic mechanism that potentially 
enables M. hyopneumoniae to inactivate four innate effector peptides that play a central role in controlling ciliary 
beat frequency, inflammation and other innate immune responses in the lungs. Specifically, we determined that 
MHJ_0569 and MHJ_0522 are retained on the cell surface of M. hyopneumoniae and that purified recombinant 
Figure 7. Cleavage of SP by rMHJ_0522 is influenced by pH and divalent metal cofactors. (a) Control 
spectra of SP illustrating a single peak at 1347.7 Da produced in the absence of rMHJ_0522. (b) Spectra of SP 
cleavage after incubation with rMHJ_0522 at pH 7.3 in the presence of Zn2+ illustrating generation of SP1-10 
(RPKPQQFFGL = 1217.0 Da), SP1-9 (RPKPQQFFG = 1104.6 Da) and SP1-8 (RPKPQQFF = 1217.0 Da) (c) 
At pH 6, only the cleavage fragment SP1-8 was produced in the presence of each of the cofactors. At pH 7.3, 
the most common cleavage fragment was SP1-8. However, the presence of Zn2+ produced additional cleavage 
fragments SP1-9 and SP1-10, as did Ca2+, albeit at lower intensities. At pH 8.8 only SP1-8 was produced. 
However, the intensities for Co2+, Mg2+ and Mn2+ were lower. EDTA suppressed cofactor mediated activity 
across all pH levels tested. Control refers to SP1-11 in the absence of rMHJ_0522.
Figure 8. Cleavage of NKA by rMHJ_0522 is influenced by pH and divalent metal cofactors. At pH 6.3 
rMHJ_0522 produced non-negligible fragments in the presence of Mg2+, Co2+ and Ca2+. At pH 7.3 and most 
intensely in the presence of Zn2+, rMHJ_0522 generated three cleavage fragments (NKA1-6, NKA1-7, and 
NKA1-8), with NKA1-8 being the most prominent. EDTA suppressed Mg2+ mediated activity at pH 6.3 and 
Zn2+ mediated activity at pH 7.5. Control refers to NKA1-10 in the absence of rMHJ_0522.
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versions of these proteases can affect the function of NPY, BK, SP and NKA. rMHJ_0659 was shown to function 
as a PepP aminopeptidase that removes N-terminal amino acids that lie adjacent to a proline residue in BK, SP, 
and NPY. rMHJ_0522 (PepF) was shown to function as an oligopeptidase that can cleave BK and the tachykinins 
NKA and SP that carry a common tachykinin C-terminal motif. These observations provide insight into the 
mechanisms used by M. hyopneumoniae that alter the microenvironment in the upper respiratory tract of the host 
in a manner that favours colonisation of ciliated epithelium.
Despite lacking translocation signal peptides, MHJ_0659 and MHJ_0522 were identified on the cell surface of 
M. hyopneumoniae. Surface localisation was demonstrated by detecting tryptic peptides released by mild enzy-
matic cell shaving, digesting biotinylated surface proteins captured by avidin chromatography using LC-MS/
MS, and by immunofluorescence microscopy. MHJ_0659 and MHJ_0522 have unique access to host proteins 
including inflammatory peptides that regulate ciliary function on epithelial cells that line the upper respiratory 
tract, the preferred niche for this pathogen. Using a MALDI-TOF MS assay, we demonstrate that, collectively, 
rMHJ_0659 and rMHJ_0522 cleave four peptides that play a central role in modulating mucociliary clearance 
and inflammation.
BK is a nonapeptide involved in the coagulation cascade, which is now known to be an integral part of innate 
immunity20. Once BK is released from the D4 domain of high molecular weight kininogen via the serine pro-
tease kallikrein, it greatly enhances bronchoconstriction, accelerates tracheobronchial and mucociliary clearance, 
and induces cough48. BK binds to mast cells, releasing histamine, leukotriene, and prostaglandins, which lead to 
increased mucous secretions in the lungs49. BK also amplifies nitric oxide production leading to increased ciliary 
beat frequency50 and can initiate a range of other immune responses51. rMHJ_0659 cleaved BK at the first two 
N-terminal amino acids R↓P↓P-G-F-S-P-F-R, and rMHJ0522 cleaved BK at R-P-P-G↓F↓S-P-F-R. The cleavage 
events demonstrated by both proteases mimic those known to inactivate BK52.
SP and NKA are neuropeptides belonging to the tachykinin superfamily, characterised by a common 
C-terminal sequence FXGLM-NH253. SP is the most extensively researched tachykinin and is best known for its 
ability to function as a neurotransmitter. However, it can also induce a repertoire of innate immune effector cells 
and inflammatory mediators54,55, and concentrations of SP are increased within inflamed tissue56. Invading bac-
teria stimulate primary sensory neurons and activate SP NK1 receptors in tissue cells promoting a local influx of 
inflammatory and immune cells57. Additionally, SP has been shown to; (i) increase intracellular calcium which in 
turn increases ciliary beat frequency58; (ii) regulate proinflammatory cytokines59; and (iii) stimulate airway sub-
mucosal gland secretion60. Interestingly, the ability of SP to boost airway submucosal gland secretion is ten-fold 
greater in pigs than in humans60. SP-induced bronchoconstriction and cough have both been reported61. However, 
the ability to induce cough has since been contested62. Like SP, NKA induces bronchoconstriction and mucus pro-
duction in the lungs as well as neurogenic inflammation63. Additionally, NKA is a potent attractor of T-cells57.
Active Lung Proteins and Peptides
N-terminal 
Sequence Tachykinins C-terminal Sequence
Alveolar macrophage chemotactic 
factor SPIEAA… Endokinin A …QFFGLM-NH2
Bradykinin RPPGFS… Hemokinin …QFYGLM-NH2
Coagulation factor XII IPPWKD… Neurokinin A …SFVGLM-NH2
Cathepsin B LPKSFD… Neurokinin B …FFVGLM-NH2
Cathepsin K TPDSID… Neuropeptide γ …SFVGLM-NH2
Growth hormone FPAMPL… Neuropeptide κ …SFVGKM-NH2








Table 2. Porcine innate immune system polypeptides that exhibit penultimate proline (left) residues and 






Table 1. Peptide substrates for rMHJ_0659 and rMHJ_0522. Bold arrows and underline arrows represent 
rMHJ_0659 and rMHJ_0522 cleavage sites respectively.
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To exert their inflammatory responses, SP and NKA need to bind NK1 and NK2 receptors present in airway 
smooth muscle, epithelium and on macrophages64. rMHJ_0659 cleaved SP at the anticipated N-terminal arginine 
residue due to the presence of a penultimate proline. While this cleavage does not inactivate SP65, it does remove 
the protective conformation that penultimate proline provides, leaving the peptide vulnerable to potential degra-
dation by other M. hyopneumoniae surface exposed aminopeptidases, such as leucine aminopeptidase47 and glu-
tamyl aminopeptidase46. On the other hand, rMHJ_0522 efficiently cleaved SP at R-P-K-P-Q-Q-F-F↓G-L-M-NH2. 
This cleavage event removes the C-terminal G-L-M-NH2 sequence essential for SP to bind tachykinin recep-
tors NK1 and NK2. At pH 7.3 in the presence of Zn2+, rMHJ_0522 produced two additional cleavages at 
R-P-K-P-Q-Q-F-F↓G↓L↓M-NH2 thus wholly degrading the G-L-M-NH2 sequence. SP fragments are known to be 
biologically active66, and previous reports have demonstrated that F-G-L-M-NH2 and G-L-M-NH2 can bind NK1 
and NK2 receptors, albeit their binding affinity is 1000 times less than that of an intact SP molecule67. rMHJ_0522 
had a similar activity to SP against NKA producing cleavages at H-K-T-D-S-F↓V↓G↓L-M-NH2 again cleaving at 
the biologically significant C-terminal sequence. Our results indicate that MHJ_0522 can potentially eradicate 
inflammation mediated by SP and NKA.
NPY is a neuropeptide that has well-recognised roles in the brain; however, NPY has also been identified 
as a potent mediator of inflammation68. Similarly to both BK and SP, NPY increases the release of proinflam-
matory cytokines and chemokines69, but is also a key activator of antigen presenting cell (APC) function68. 
Additionally, allergic airway inflammation in NPY deficient mice is significantly reduced70. rMHJ_0659 removed 
N-terminal tyrosine off NPY. All cofactors tested greatly enhanced rMHJ_04659 activity against NPY at pH 8.8. 
At a more neutral pH, Ca2+ was the most efficient cofactor. The most prominent NPY receptors in the lungs are 
Y1 receptors, which potentate local inflammatory responses and are also widely expressed on T cells, B cells and 
APCs68. Importantly, studies have demonstrated that removing Y from the N-terminus of NPY diminishes Y1 
receptor-binding efficiency and the resultant NPY2-36 fragment is a selective Y2 receptor agonist71. Y2 receptor 
agonists have been linked to a reduction in food intake72. Our data suggest that cleavage events caused by the 
action of MHJ_0659 have the potential to minimise Y1 receptor effects and increase Y2 receptor effects.
The data presented here and elsewhere provide a body of evidence to suggest that proteases play an essential 
role in the pathogenesis of M. hyopneumoniae by processing adhesins, lipoproteins and other putative patho-
genicity factors15, destroying host innate immunity effector peptides and neuropeptides, recycling amino acids 
for nutrients42,43 and by inducing apoptosis14. Here we demonstrate novel functions for M. hyopneumoniae surface 
proteases. Our work provides insight into how genome-reduced pathogens colonise and persist in their chosen 
host.
Material and Methods
Materials. Ethylenediaminetetraacetic acid (EDTA), tributylphosphine (TBP), bovine serum albumin (BSA), 
SP, BK, NKA and NPY were purchased from Sigma (Australia). MS grade trypsin was purchased from Promega 
(USA). Acrylamide was purchased from Bio-Rad (USA). Immunofluorescence dyes, pre-cast gels, buffers, 
molecular weight markers and all standard molecular biology reagents were purchased from Life Technologies 
(Australia) unless otherwise noted.
Mycoplasma hyopneumoniae culture conditions. M. hyopneumoniae strain J was cultured in modified 
Friss73 medium for 48 h at 37 °C and harvested by centrifugation at 12 000 × g for 15 min. Pellets were stored at 
−80 °C until use.
cell surface analyses of Mycoplasma hyopneumoniae proteins. All surface exposed M. hyopneumo-
niae proteins were identified using both cell surface biotinylation and trypsin cell surface shaving experiments as 
previously described36. Briefly, for enzymatic cell surface experiments freshly cultured and washed M. hyopneu-
moniae cells were digested with 50 µg/mL trypsin in PBS at 37 °C for 5 min. Any tryptic peptides released were 
analysed by LC-MS/MS. For surface protein biotinylation, freshly cultured M. hyopneumoniae cells were washed 
and pelleted by centrifugation and then biotinylated with sulfo-NHS-LC biotin (Thermo Scientific) for 30 s. 
Biotinylated proteins were captured and purified by avidin column affinity chromatography and then separated 
by 2D SDS-PAGE and examined using LC-MS/MS. A full peptide list of M. hyopneumoniae surface proteins74 and 
proteome75 have been previously published.
Antisera generation. Polyclonal antibodies against rMHJ_0659 and rMHJ_0522 were raised in rabbits by 
the Institute of Medical and Veterinary Science (Australia).
Western blot. Once SDS-PAGE gel containing a freshly purified recombinant protease sample was electro-
phoretically transferred, the membrane was washed in PBS with 0.1% Tween [Bio-Rad, USA] for 20 min and then 
blocked with PBS, 0.1% Tween and 5% skim milk powder for 30 min to prevent non-specific antibody binding. To 
check specific binding to generated anti-recombinant protease sera, the membrane was then placed in a solution 
containing primary antibody at a 1:1000 dilution in PBS for 90 min before being washed three times with PBS and 
probed with peroxidase conjugated anti-rabbit secondary antibody [Sigma Aldrich, USA] diluted to 1:10,000 in 
blocking solution for 30 min at room temperature. The membrane was again washed briefly three times in PBS 
before being developed with 3,3′-Diaminobenzidine (DAP) [Sigma Aldrich, USA].
Immunofluorescence microscopy. Microscopy was performed as previously described46 with mini-
mal modifications. A 35 mm WPI Fluorodish was coated with 0.01% poly-l-lysine for 30 min and allowed to air 
dry for 30 min. An overnight M. hyopneumoniae culture was centrifuged (11 000 × g for 10 min) and washed 
twice with sterile PBS. Washed cells were added to the Fluorodish and allowed to attach for 30 min. Excess cells 
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were removed by washing once with PBS followed by fixation in 2% paraformaldehyde at 4 °C overnight. Excess 
aldehydes were quenched using 100 mM glycine in PBS for 5 min, followed by washing three times with PBS. 
Non-specific binding sites were blocked with 2% BSA in PBS for 1 h at room temperature, followed by wash-
ing three times with PBS. Polyclonal rabbit rMHJ_0522 and rMHJ_0659 antisera were diluted 1:500 with PBS 
containing 2% BSA, incubated for 1 hr at room temperature and washed three times in PBS. A 1:1000 dilution 
of goat anti-rabbit antibodies conjugated to CF™ 568 (Sigma-Aldrich) was prepared in PBS containing 2% BSA 
and incubated for one hr at room temperature and washed three times in PBS. The liquid was removed from the 
Fluorodish which was allowed to air dry for 15 min. Two drops of VECTASHIELD were added to the Fluorodish 
followed by imaging on a Nikon Ti inverted epifluorescence microscope, capturing images using a DS-Qi2 micro-
scope camera (Nikon Instruments). These same samples were imaged on a V3 DeltaVision OMX 3D-Structured 
Illumination Microscopy Imaging System (Applied Precision, GE Healthcare) as previously described76. Images 
were processed using Imaris Scientific 3D/4D image processing software (Bitplane AG).
Expression and purification of rMHJ_0659 and rMHJ_0522. The mhj_0659 and mhj_0522 genes 
encoding PepP and PepF respectively were ligated into expression vector PS100030, conveying both a hexahisti-
dine tag and ampicillin resistance, by Blue Heron Biotech (USA). All in-frame TGA codons were substituted to 
TGG. The recombinant construct was transformed into E. coli BL21 (Invitrogen) as per the manufacturer instruc-
tions and grown overnight in LB supplemented with 100 mg/mL ampicillin. LB supplemented with 100 mg/mL 
ampicillin was inoculated with overnight transformation culture and grown until mid-log growth phase. Cultures 
were then induced with IPTG and grown to optimal protein expression levels (4 hrs for rMHJ_0522, 6 hrs for 
rMHJ_0659). Cells were harvested by centrifugation at 3000 × g for 10 min at 4 °C. Pellets were resuspended in 
Lysis Buffer [50 mM NaH2PO4, 300 mM NaCl, 10 mM imidazole, pH 8) at 2 mL per gram of wet weight and 
lysozyme (Sigma Aldrich) was added at 1 mg/mL to break down peptidoglycan. Resuspended pellets were incu-
bated on ice for 30 min and then probe sonicated with 6 × 10-sec bursts at 400 W and 10 sec cooling period on 
ice between bursts. Cell debris was removed by centrifugation at 10,000 × g for 30 min at 4 °C and the cleared cell 
lysate was added to 50% slurry of Profinity immobilized metal affinity chromatography (IMAC) Ni2+ charged 
resin (Bio-Rad) at a volume of 1 mL slurry per 1 L starting culture, and left overnight on a rotary shaker at 4 °C. 
Both recombinant proteins were then purified under native conditions using imidazole, dialysed against PBS in 
10 K MWCO dialysis tubing, and stored at 4 °C. 1D SDS-PAGE was used to separate purified protein samples.
proteomics. To analyse purified protein samples separated by 1D SDS-PAGE, peptide preparation by trypsin 
in-gel digestion, and LC-MS/MS analysis parameters were followed as described previously46. A novel assay was 
used to determine substrate cleavage. From a stock solution (1 mg/ml) of BK, SP, NKA or NPY (Sigma Aldrich) 
1 µl was diluted in 8.5 µL 50 mM Tris-HCl buffer (pH 6.3–8.8) or 50 mM sodium acetate (pH 5) and 0.5 µL 
100 mM cofactor (Ca2+, Co2+, Mg2+, Mn2+, or Zn2+). Purified rMHJ_0659 or rMHJ_0522 was added in a 1:20 
protease to substrate concentration and incubated for 1 hr at 37 °C. The peptides were then desalted and captured 
using C18 ZipTips (Millipore). 1 µl of peptide sample was later spotted onto a clean 384-well OptiTOF target plate 
(AB Sciex) followed by 1 µl of 5 mg/ml α-Cyano-4-hydroxycinnamic acid (CHCA) dissolved in 50% ACN, 0.1% 
TFA, 10 mM NH4H2PO4 and allowed to dry. Spotted samples were then analysed using a 5800 MALDI-TOF/TOF 
MS in positive reflector mode for BK, NKA and SP, and linear mode for NPY due to substrate size. Laser intensity 
was set to 2600 for MS parent ion scans. 400 laser shots were averaged for MS scans. MS parent ion scans were 
calibrated using a 6-peptide mixture (Sciex). The resulting MS spectral data were then manually inspected to 
explain the ions present concerning their amino acid sequence and the cleavage events caused by PepP and PepF 
proteolysis. For inhibition studies, rMHJ_0659 or rMHJ_0522 was pre-incubated with 10 mM metal chelating 
agent EDTA for 20 min at 37 °C, before repeating substrate cleavage assays using the cofactor that had previously 
demonstrated highest activity at each pH level tested.
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